Advance Formula Pain Reliever tablets recalled for failed stability specifications
Ultra Seal Corporation is recalling Advance Formula Pain Reliever tablets (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) distributed nationwide due to out-of-specification results for Salicylic Acid, an Aspirin-related compound.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving out-of-specification stability test results for an impurity (Salicylic Acid). Class III recalls are typically scored 1 or 2. The source text does not report any illnesses, injuries, or deaths, and the hazard is a manufacturing/quality issue rather than an active safety threat. A score of 2 reflects precautionary monitoring of a quality defect.
Plain-English summary
Ultra Seal Corporation is recalling Advance Formula Pain Reliever tablets containing Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg, packaged as 2 tablets per packet. The recall affects 991,310 tablets manufactured for Advanced First Aid (Baltimore, MD) and American Safety & First Aid (Osceola, IN).
The recall was initiated due to failed stability specifications. Out-of-specification results were observed for Salicylic Acid, an Aspirin-related compound. The affected lots are: AK-9457 (expiration 22-Jan), AK-9521 (expiration 22-Mar), AK-9959 (expiration 22-Dec), and AK-1017 (expiration 23-Jan).
The product was distributed nationwide in the USA. Consumers who have purchased this product should stop using it and contact the manufacturer or healthcare provider with questions.
The recalled product
- Product
- Advance Formula Pain Reliever (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets Per Packet, Packaged in 12,000 Packets/Case, PO# 007564-00, Item# 1170, Mfg. for: Advanced First Aid, Baltimore, MD 21237; American Safety & First Aid, Osceola, IN 46561 (Shippin
- Manufacturer
- Ultra Seal Corporation
- Hazard
- stability-test-failure
- out-of-specification-impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: AK-9457
- exp. date 22-Jan
- AK-9521
- exp. date 22-Mar
- AK-9959
- exp. date 22-Dec
- AK-1017
- exp. date 23-Jan
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27